28
Oct
2025
Alkaloid AD Skopje
Exhibitor at CPHI Frankfurt 2025 stand 3.1D12, Finished Dosage Formulations
About Us
Categories
-
MK
-
2015On CPHI since
-
2Certificates
-
1000 - 4999Employees
Company types
Primary activities
Event information
CPHI Frankfurt 2025
-
28 Oct 2025 - 30 Oct 2025
-
Messe, Frankfurt
-
Visit us at stand 3.1D12, Finished Dosage Formulations
Products Featured at CPHI Frankfurt 2025
-
Product Ibuprofen gel
5% topical gel -
Product Ibuprofen/Paracetamol
200mg/500mg film coated tablets -
Product Lisinopril/Amlodipine tablets
10mg/5mg 20mg/5mg 20mg/10mg -
Product Omeprazole oral solution
10mg/15ml; 20mg/15ml -
Product Ibuprofen / paracetamol film-coated tablets (200 mg / 500 mg)
analgesic / antipyretic
-
Product Flecainide tablets (50 mg, 100 mg )
antiarrhythmic -
Product Levomethadone oral solution (5 mg/5 ml)
opioid analgesic -
Product Methadone concentrate for oral solution (10 mg/ml )
substitute for opioid dependence -
Product Methadone oral solution (1 mg/ml)
substitute for opioid dependence -
Product Ibuprofen lysine film-coated tablets (684 mg)
analgesic / antipyretic
-
Product Ibuprofen lysine film coated tablets ( 342 mg)
analgesic / antipyretic -
Product Ibuprofen oral suspension (200 mg / 5 ml)
analgesic / antipyretic -
Product Ibuprofen oral suspension (100 mg / 5 ml)
analgesic / antipyretic -
Product Cold and flu film-coated tablets (500 mg/30 mg/ 15 mg/60 mg )
Paracetamol / Pseudoephedrine / Dextromethorphan / Ascorbic acid (500 mg/30 mg/ 15 mg/60 mg )analgesic, antipyretic / decongestant / antitussic / vitamin C -
Product Bisoprolol film-coated tablets (2.5 mg, 5 mg, 10 mg)
antihypertensive / antianginal / medicine for treatment of heart failure -
Product Cefadroxil capsules, hard (500 mg)
antibiotic -
Product Zolpidem film coated tablets (5 mg, 10 mg)
hypnotic and sedative
-
Product Lisinopril / hydrochlorothiazide tablets (20mg / 12.5mg)
antihypertensive -
Product Oxymetazoline nasal drops, solution (0.25 mg/ml, 0.5 mg/ml)
nasal decongestant -
Product Ibuprofen topical gel ( 5% )
Dossier in development - analgesic -
Product Diclofenac diethylamine topical gel (1.16%, 2.32%)
Dossier in development - analgesic -
Product Ramipril film-coated tablets (1.25mg; 2.5mg; 5mg; 10mg )
antihypertensive -
Product Antacid oral (sodium alginate / potassium bicarbonate)
Dossier in development - antacid oral suspension (500 mg + 100 mg) / 5ml -
Product Antacid triple (sodium alginate / sodium bicarbonate / calcium carbonate)
Dossier in development - antacid chewable tablets 250 mg / 133.5 mg / 80 mg -
Product Dimetindene maleate topical gel ( 0.1 % )
antipruritic, antihistamine -
Product Omeprazole oral solution (10mg/15ml; 20mg/15ml )
First ready to drink omeprazole in liquid form
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance